The Case for Prohibiting the Sale of Individual Genetic Testing Data to Third Parties
Nathaniel Jaffe Genetic technology is getting cheaper, and millions of individuals are using direct-to-consumer genetic testing (DTC-GT) services. At the same time, the scientific understanding of genetics is improving, making sequencing information more valuable for predictive medicine, research, forensics, and many other fields. In turn, genetic information has become more valuable for third parties like insurers, researchers, and pharmaceutical companies. DTC-GT providers are in a position to provide increasingly low-cost services to a growing consumer base, while stockpiling data of increasing commercial value. The sale of genetic data threatens the privacy of the individuals who provided it and opens them...
The Case for the Use of Facial Recognition Technology
Ye-Eun Sung Consumers often unknowingly enter brick-and-mortar stores that utilize facial recognition technology. Many are, therefore, at risk of their biometric data being wrongfully used without their consent or knowledge. The delay in the courts’ and the federal government’s response to facial recognition technology has allowed its development and use to remain unregulated. Although regulation of this technology is essential, its use should not be banned outright. Due to the changing retail landscape, facial recognition technology provides brick-and-mortar stores with information that allows them to remain relevant in a market that relies significantly on the internet and e-commerce. Read Full...